These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24429112)

  • 21. Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?
    Jones PW
    Am J Respir Crit Care Med; 2009 Oct; 180(8):689-90. PubMed ID: 19805796
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical Inquiry: what are the benefits and risks of inhaled corticosteroids for COPD?
    Hamilton T; Miller JB; Vincent EC; St Anna L
    J Fam Pract; 2014 May; 63(5):276-8. PubMed ID: 24795909
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease.
    Johnson M
    Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled combination therapy with long-acting beta 2-agonists and corticosteroids in stable COPD.
    Cazzola M; Dahl R
    Chest; 2004 Jul; 126(1):220-37. PubMed ID: 15249466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relvar Ellipta for asthma.
    Drug Ther Bull; 2014 Aug; 52(8):93-6. PubMed ID: 25125553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of new onset diabetes mellitus in patients with asthma or COPD taking inhaled corticosteroids.
    O'Byrne PM; Rennard S; Gerstein H; Radner F; Peterson S; Lindberg B; Carlsson LG; Sin DD
    Respir Med; 2012 Nov; 106(11):1487-93. PubMed ID: 22902134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
    Nishimura K
    Nihon Rinsho; 2003 Dec; 61(12):2181-6. PubMed ID: 14674330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential side effects in patients treated with inhaled corticosteroids and long-acting beta2-agonists.
    Korsgaard J; Ledet M
    Respir Med; 2009 Apr; 103(4):566-73. PubMed ID: 19136239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Obstructive Pulmonary Disease: When Pulmonologists Do Something Good for the Heart.
    Watz H
    Am J Respir Crit Care Med; 2016 Apr; 193(7):703-4. PubMed ID: 27035775
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical effectiveness of synergic therapy].
    Płusa T; Lubiński W
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():20-2. PubMed ID: 15524008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weaning from inhaled corticosteroids in COPD: the evidence.
    Suissa S; Rossi A
    Eur Respir J; 2015 Nov; 46(5):1232-5. PubMed ID: 26521271
    [No Abstract]   [Full Text] [Related]  

  • 33. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF
    Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Inhaled corticosteroids in COPD--between pro and con?].
    Mihalţan F
    Pneumologia; 2009; 58(4):204-5. PubMed ID: 20067052
    [No Abstract]   [Full Text] [Related]  

  • 35. A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD.
    Kerwin EM; Scott-Wilson C; Sanford L; Rennard S; Agusti A; Barnes N; Crim C
    Respir Med; 2013 Apr; 107(4):560-9. PubMed ID: 23352226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study].
    Buhl R; Kardos P; Magnussen H; Matthys H; Sauer R; Schauer P; Vogelmeier C; Wettengel R; Worth H; Menz G
    Pneumologie; 1999 Apr; 53(4):210-2. PubMed ID: 10409864
    [No Abstract]   [Full Text] [Related]  

  • 37. [Once daily with a powder inhaler].
    Fath R
    MMW Fortschr Med; 2015 Jun; 157(11):66. PubMed ID: 26049359
    [No Abstract]   [Full Text] [Related]  

  • 38. Could Pharmacologic Lung Deflation Modify Cardiac Structural and Functional Alterations?
    Savas G; Kalay N; Gulmez I
    Am J Respir Crit Care Med; 2016 Apr; 193(8):932. PubMed ID: 27082537
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 40. Do inhaled corticosteroids slow FEV1 decline in COPD after all?
    Duerden MG
    Thorax; 2004 Jun; 59(6):538-9; author reply 539-40. PubMed ID: 15170045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.